Quantum BioPharma announces a whistleblower policy offering rewards for information on stock manipulation, amid ongoing litigation against major financial institutions.
Quantum BioPharma Ltd. has announced a public whistleblower policy offering up to USD $7 million in rewards for individuals who provide verifiable evidence of stock manipulation related to the Company. This initiative comes amid a lawsuit against several major financial institutions, alleging they engaged in illegal trading tactics, such as spoofing, to depress the Company's stock price. The lawsuit seeks over USD $700 million in damages following a significant drop in share value. Eligible whistleblowers, excluding current employees or law enforcement, can report their findings confidentially to the Company, which emphasizes accountability and market integrity. The legal action, led by experienced law firms, aims to highlight broader manipulation in the market and encourages simultaneous reporting to regulatory authorities, while maintaining confidentiality as allowed by law.
Aussie cricket coach Andrew McDonald has rejected suggestions from England that Scott Boland could be a major weakness for the Australians in the Ashes. Boland looks set to play a huge role in the ...